Meet Senzime at the Swiss-Scandinavian Bio-Business Seminar

Meet Senzime at the Swiss-Scandinavian Bio-Business Seminar. Lena Söderström CEO is attending.

The 9^th Swiss-Scandinavian Bio-Business Seminar is organized by the Nordic countries in cooperation with Swiss partners. During this high-level partnering and investor conference, Swiss and Nordic biotech and pharmaceutical companies as well as investors meet in one-to-one meetings and present themselves in plenum.

The goal of the conference and by means of the Swiss-Nordic focus is to establish new contacts and networks. The conference has a broad focus within biotech, pharma and medical device and gathers small, early stage companies as well as global, commercial corporations.

The conference is open for biotech and pharma companies as well as investors within the life science industry.

When: February 5, 2015 from 08:00-18:00
Where: SIX Stock Exchange building in Zurich.

More info:

http://www.b2match.eu/ssbbs2015

TO THE EDITORS

About Senzime

Senzime develops and sells analytical instruments and related disposable products that enable automated, continuous monitoring of vital substances including glucose (sugar), in biological fluids.
Many modern medicines are produced in living cells that are nourished in a glucose solution. In order to ensure maximum productivity in manufacturing, glucose levels should be measured continuously. BioSenz^TM is an analytical instrument that performs this task. Senzime's market leading partner,  Applikon, has started the global launch of BioSenz. Continuous glucose monitoring can also be used by healthcare providers, to improve outcomes of complex surgical procedures and dialysis care. For these purposes, the company develops the instrument CliniSenz^TM. The company's share is listed on Aktietorget since 2008.  www.senzime.com